ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

NEW YORK and TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that…

Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference

ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York

SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that chief executive officer Kristin Yarema, Ph.D., will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference…

Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment ...

SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announces that it will participate in the H.C. Wainwright 28th Annual…

H.C. Wainwright to Convene Industry Leaders Across AI, Digital Infrastructure and Digital Asset Treasuries at 28th Annual Global Investment Conference

NEW YORK--(BUSINESS WIRE)--Sep 8, 2026-

Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment ...

WEST CHESTER, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological diseases, including skin cancers, today announced that Jayson Rieger, PhD, MBA, President and…